Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
The aim of this study was to compare the efficacy and safety of concurrent chemoradiotherapy (CCRT) vs accelerated hyperfractionation with concomitant boost (CCB) as a primary treatment for patients with Stage 3-5 squamous cell carcinoma of head and neck (SCCHN). A total of 85 non-metastatic advance...
Saved in:
Main Authors: | Chitapanarux I., Kamnerdsupaphon P., Pukanhapan N., Tharavichitkul E., Vongtama R. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84888263886&partnerID=40&md5=e34ee637c9b4423116ed3261e446f0d3 http://cmuir.cmu.ac.th/handle/6653943832/4237 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
by: Imjai Chitapanarux, et al.
Published: (2018) -
Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
by: Imjai Chitapanarux, et al.
Published: (2018) -
Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: A randomised comparison
by: Soo, K.-C., et al.
Published: (2014) -
Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
by: Chitapanarux I., et al.
Published: (2014) -
Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer
by: I. Chitapanarux, et al.
Published: (2018)